search 2013 adfgs

BusinessWire News

BusinessWire has been designated by BioNJ as its preferred distributor of news releases to the life sciences news media and investment community.

  • The Medicines Company Reports Third Quarter and First Nine Months 2014 Results October 22, 2014
    PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO), a global biopharmaceutical company focused on saving lives, alleviating suffering, and contributing to the economics of healthcare by focusing on the world's leading acute/intensive care hospitals, today announced third quarter and first nine month results for 2014. Financial highli […]
  • Veeva Vault Selected by inVentiv Health Clinical to Empower Sponsors with Cloud-based eTMF Clinical Trial Platform October 21, 2014
    PLEASANTON, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--inVentiv Health Clinical, a leading global supplier of drug development services, will replace its electronic trial master file (eTMF) content management system with Veeva Vault eTMF. Cloud-based, multitenant Vault eTMF delivers secure, instant access to inspection-ready documentation and enables sea […]
  • STENTYS Wins Large Regional Tender in Middle East October 20, 2014
    PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS Wins Large Regional Tender in Middle East
  • Catalent, Inc. Announces First Quarter Fiscal Year 2015 Earnings Conference Webcast October 16, 2014
    SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will release financial results for the first quarter of fiscal year 2015 ended September 30, 2014 after the market close on […]
  • ADMA Biologics to Present “Ascending Company” Presentation at BioNJ CEO Summit October 16, 2014
    RAMSEY, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced it is scheduled to present at the BioNJ CEO Summit Conference at 9:30 AM ET on October 21, […]